VAUGHAN, ON, Jan. 8, 2019 /PRNewswire/ - CannTrust Holdings
Inc. ("CannTrust" or the "Company", TSX: TRST), one
of Canada's leading, most trusted
licensed producers of cannabis and the 2018 Canadian Cannabis
Awards "Top Licensed Producer of the Year", announces that it has
applied to list its common shares on the New York Stock Exchange
(the "NYSE").
Listing of the Company's common shares on the NYSE remains
subject to the approval of the NYSE and the satisfaction of all
applicable listing and regulatory requirements. In connection with
the intended listing on the NYSE, the Company has filed a
registration statement on Form 40-F (the "Registration
Statement") with the United States Securities and Exchange
Commission (the "SEC"). The Registration Statement has not
yet been declared effective by the SEC. Upon receipt of all
required approvals and completion of the formal listing process,
the Company will publicly announce its first trading date on the
NYSE.
"CannTrust has firmly established itself as one of the top
licensed producers in Canada with a global platform
rooted in trust, science and innovation," said Peter Aceto,
CEO of CannTrust. "A listing on the NYSE is a natural step forward
in our evolution as we look to broaden our investor base, increase
the Company's exposure and expand our business on an international
scale."
About CannTrust
CannTrust is a federally regulated
licensed producer of medical and recreational cannabis in
Canada. Founded by pharmacists,
CannTrust brings more than 40 years of pharmaceutical and
healthcare experience to the medical cannabis industry and serves
over 57,000 medical patients with its dried, extract and capsule
products. The Company operates its 450,000 sq. ft. Niagara
Perpetual Harvest Facility. The industry's broadest product
portfolio is prepared and packaged at the 60,000 sq. ft.
manufacturing centre of excellence in Vaughan, Ontario.
CannTrust is developing nanotechnology to develop new products
in the medical, recreational, beauty, wellness and pet markets. The
Company has established its international footprint through a
strategic partnership with Cannatrek Ltd. in Australia and a joint venture with STENOCARE
in Denmark. The Company has also
partnered with Breakthru Beverage Group through Kindred Canada, for
recreational distribution in Canada. CannTrust is committed to research and
innovation. Its partnerships with McMaster
University in Ontario and
Gold Coast University in
Australia were designed to
contribute to the growing body of evidence-based research regarding
the use and efficacy of cannabis.
CannTrust was proudly voted Top Licensed Producer of the Year at
the 2018 Canadian Cannabis Awards. For more information, please
visit www.canntrust.ca.
Forward Looking Statements
This press release contains
"forward-looking information" and "forward-looking statements"
within the meaning of applicable securities legislation which are
based upon CannTrust's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information and forward-looking statements can be
identified by the use of forward-looking terminology such as
"expect", "likely", "may", "will", "should", "intend",
"anticipate", "potential", "proposed", "estimate" and other similar
words, including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy.
The forward-looking information and statements in this news
release are based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information and
statements includes estimates, plans, expectations, opinions,
forecasts, projections, targets, guidance or other statements that
are not statements of fact. Forward-looking statements in this news
release include, but are not limited to, statements with respect to
the approval to list the Company's common shares on the NYSE.
Forward-looking information and statements necessarily involve
known and unknown risks, including, without limitation: risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; the cannabis industry in Canada generally;
the ability of CannTrust to implement its business strategies;
obtaining NYSE and SEC approval to list CannTrust's common shares;
any delays related to obtaining such approvals as a result of the
current shutdown of the US Federal government and other risks.
Any forward-looking information and statements speaks only as of
the date on which they are made, and, except as required by law,
CannTrust does not undertake any obligation to update or revise any
forward-looking information or statements, whether as a result of
new information, future events or otherwise. New factors emerge
from time to time, and it is not possible for CannTrust to predict
all such factors. When considering these forward-looking
information and statements, readers should keep in mind the risk
factors and other cautionary statements in CannTrust's Annual
Information Form dated March 29, 2018 (the "AIF")
and filed with the applicable Canadian securities regulatory
authorities on SEDAR at www.sedar.com. The risk factors and
other factors noted in the AIF could cause actual events or results
to differ materially from those described in any forward-looking
information or statements.
The TSX does not accept responsibility for the adequacy or
accuracy of this release.
Copyright © 2019 CannTrust Holdings Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canntrust-applies-to-list-on-nyse-300774686.html
SOURCE CannTrust Holdings Inc.